| 2 | 1/1 | 返回列表 |
| 查看: 681 | 回復: 1 | |||
[交流]
怎么翻譯啊求助,JBT-101是什么求告知
|
|
abstract Ajulemic acid, a side-chain analog of D8 -THC-11-oic acid, was designed as a potent therapeutic agent free of the psychotropic adverse effects typical of most cannabinoids. Subsequent studies of ajulemic acid have yielded widely divergent findings on the occurrence of these adverse effects. To help resolve these discrepancies, we have prepared highly purified ajulemic acid using a different synthetic method than previously reported in the literature and compared its cannabinoid receptor binding constants with those obtained using several other preparations from different sources. Whereas CB2 binding did not vary greatly among all of the samples, the CB1 binding showed a wide range of affinities. The highly purified product (JBT-101) reported here had the weakest affinity for CB1 while the original preparation (HU-239) showed the strongest affinity for CB1. The CB1/CB2 ratio of affinities was 12.3 for JBT-101 whereas that for HU-239 was 0.19, a 65-fold difference. Functional responses such as catalepsy and hypothermia using JBT-101 versus HU-239 displayed reduced CB1 activity in keeping with the receptor binding data. Thus, earlier conclusions on the limited therapeutic index for ajulemic acid need to be reconsidered in the light of the data now obtained using JBT-101. 發(fā)自小木蟲Android客戶端 |
|
abstract Ajulemic acid, a side-chain analog of D8 -THC-11-oic acid, was designed as a potent therapeutic agent free of the psychotropic adverse effects typical of most cannabinoids. Subsequent studies of ajulemic acid have yielded widely divergent findings on the occurrence of these adverse effects. To help resolve these discrepancies, we have prepared highly purified ajulemic acid using a different synthetic method than previously reported in the literature and compared its cannabinoid receptor binding constants with those obtained using several other preparations from different sources. Whereas CB2 binding did not vary greatly among all of the samples, the CB1 binding showed a wide range of affinities. The highly purified product (JBT-101) reported here had the weakest affinity for CB1 while the original preparation (HU-239) showed the strongest affinity for CB1. The CB1/CB2 ratio of affinities was 12.3 for JBT-101 whereas that for HU-239 was 0.19, a 65-fold difference. Functional responses such as catalepsy and hypothermia using JBT-101 versus HU-239 displayed reduced CB1 activity in keeping with the receptor binding data. Thus, earlier conclusions on the limited therapeutic index for ajulemic acid need to be reconsidered in the light of the data now obtained using JBT-101. 發(fā)自小木蟲Android客戶端 |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085600,材料與化工321分求調(diào)劑 +10 | 大饞小子 2026-03-28 | 10/500 |
|
|---|---|---|---|---|
|
[碩博家園] 求調(diào)劑 有機化學考研356分 +4 | Nadiums 2026-03-25 | 5/250 |
|
|
[考研] 各位老師好,我的一志愿為北京科技大學085601材料專碩 +9 | Koxui 2026-03-28 | 9/450 |
|
|
[考研] 320分,材料與化工專業(yè),求調(diào)劑 +9 | 一定上岸aaa 2026-03-27 | 13/650 |
|
|
[考研] 一志愿中南大學化學0703總分337求調(diào)劑 +5 | niko- 2026-03-27 | 5/250 |
|
|
[考研] 394求調(diào)劑 +3 | 好事多磨靜候佳?/a> 2026-03-26 | 5/250 |
|
|
[考研]
|
y7czhao 2026-03-26 | 10/500 |
|
|
[考研] 322求調(diào)劑 +5 | 舊吢 2026-03-24 | 5/250 |
|
|
[考研] 085602 307分 求調(diào)劑 +7 | 不知道叫什么! 2026-03-26 | 7/350 |
|
|
[考研] 265求調(diào)劑 +8 | 小木蟲085600 2026-03-27 | 8/400 |
|
|
[考研] 一志愿211院校 344分 東北農(nóng)業(yè)大學生物學學碩,求調(diào)劑 +5 | 丶風雪夜歸人丶 2026-03-26 | 8/400 |
|
|
[考研] 0856調(diào)劑 +5 | 求求讓我有書讀?/a> 2026-03-26 | 6/300 |
|
|
[考研] 0703化學一志愿南京師范大學303求調(diào)劑 +3 | zzffylgg 2026-03-24 | 3/150 |
|
|
[考研] 321求調(diào)劑 +6 | Ymlll 2026-03-24 | 6/300 |
|
|
[考研] 327求調(diào)劑 +7 | prayer13 2026-03-23 | 7/350 |
|
|
[考研] 調(diào)劑 +4 | 柚柚yoyo 2026-03-26 | 4/200 |
|
|
[考研]
材料調(diào)劑
5+4
|
想要一壺桃花水 2026-03-25 | 10/500 |
|
|
[考研] 309求調(diào)劑 +4 | gajsj 2026-03-25 | 5/250 |
|
|
[考研] 347求調(diào)劑 +4 | L when | 4/200 |
|
|
[考研] 接收2026碩士調(diào)劑(學碩+專碩) +4 | allen-yin 2026-03-23 | 6/300 |
|